Back to News
Market Impact: 0.3
Haemonetics Corporation Reports Second Quarter Fiscal 2027 Revenue of $357.8 million
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Haemonetics reported fiscal Q2 2027 revenue of $357.8 million, up 9.3% year over year, with organic revenue growth of 10.0%. The provided article excerpt contains no earnings, guidance, or market-reaction details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
HAE0.55
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook